Investor Presentaiton

Accelerating Innovation Across Life Sciences DBS GROWTH TOOLS INCREASING THE CADENCE OF INNOVATION AVG. ANNUAL CORE REVENUE GROWTH IMPROVEMENT 20 20 PROBLEM TO PORTFOLIO ACCELERATED PRODUCT DEVELOPMENT PRODUCT LAUNCH EXCELLENCE AT SCIEX -40% AT 2021 REVENUE GROWTH ATTRIBUTED TO NEW PRODUCTS 2012-2016 2017-2022 SCIEX MSD HSD BECKMAN COULTER Life Sciences >30 NEW PRODUCTS LAUNCHED SINCE 2018 BECKMAN COULTER Life Sciences LSD LDD AT Leica >40% MICROSYSTEMS LSD MSD MICROSYSTEMS INCREASE IN REVENUE FROM NEW PRODUCTS LAST 3 YEARS Leica Enhancing our growth trajectory with DBS-led innovation DANAHER

View entire presentation